Filter
13
Text search:
Alvar,
J.
Featured
1
1
Language
Document type
8
2
1
1
1
Countries / Regions
2
2
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
5
2
1
1
1
Toolboxes
7
1
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most
...
In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in patients living with HIV (PLHIV) is higher. It is important t
...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported
...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv
...
Rreport of a WHO Consultative Meeting Kolkata India 2012
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani
...
Climate change triggers mounting food insecurity, poverty and displacement in Africa
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
El objetivo es proveer al equipo de salud, una guía de diagnóstico y terapéutica clínica, tanto farmacológica como no farmacológica, con recomendaciones basadas en evidencia de la mejor calidad disponible y adaptada al marco local.
Los usuarios de la Guía son todos los integrantes del
...
